Literature DB >> 2479665

Lectin binding properties of cells from serous effusion and peritoneal washing specimens.

P W Shield1.   

Abstract

The diagnostic value of staining cells from serous effusion and peritoneal washing specimens with a panel of four lectins was investigated and the results compared with those achieved with polyclonal anti-carcinoembryonic antigen (anti-CEA) sera. Cell blocks from 42 pleural effusions, 25 peritoneal effusions, and 14 peritoneal washing specimens were stained with Con A (D-mannosyl, D-glucosyl), WGA (n-acetyl glucosamine), UEA-1 (L-fucose), SBA (n-acetyl galactosamine) and anti-CEA. Con A and WGA were not useful in discriminating mesothelial cells from adenocarcinomas. In contrast, UEA-1 and SBA binding was present in 30 of 46 (65%) and in 31 of 46 (67%), respectively, of adenocarcinomas tested, but negative in 21 cases with reactive mesothelial cells, 10 cases with benign mesothelial cells, and one case of mesothelioma. All mesothelial cells were also negative for CEA, but 24 of 46 (52%) of adenocarcinomas were positive. All three cases of lymphoma were negative with UEA-1, SBA, and anti-CEA. UEA-1 and SBA lectins identified a higher proportion of metastatic adenocarcinomas than CEA and stained most cases of adenocarcinomas metastatic from sites which usually fail to express CEA. Combination of staining results for UEA-1, SBA, and anti-CEA produced a test with high sensitivity and specificity, identifying 40 of 46 (87%) of adenocarcinomas tested, with no false positive results. It is concluded that UEA-1 and SBA staining of effusion specimens warrants further study, and may provide a useful adjunct to CEA staining.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479665      PMCID: PMC501978          DOI: 10.1136/jcp.42.11.1178

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  A and B blood-group antigens on human epidermal cells demonstrated by mized agglutination.

Authors:  R R COOMBS; D BEDFORD; L M ROUILLARD
Journal:  Lancet       Date:  1956-04-21       Impact factor: 79.321

Review 2.  Immunoperoxidase technique in histopathology: applications, methods, and controls.

Authors:  E Heyderman
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

3.  Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.

Authors:  E M Rutanen; J Lindgren; P Sipponen; U P Stenman; E Saksela; M Seppäla
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

4.  Cell surface glycolipids and glycoproteins in malignant transformation.

Authors:  G Yogeeswaran
Journal:  Adv Cancer Res       Date:  1983       Impact factor: 6.242

5.  Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycosylproteins.

Authors:  H Debray; D Decout; G Strecker; G Spik; J Montreuil
Journal:  Eur J Biochem       Date:  1981-06

6.  Glycosphingolipids as tumor-associated and differentiation markers.

Authors:  S Hakomori; R Kannagi
Journal:  J Natl Cancer Inst       Date:  1983-08       Impact factor: 13.506

7.  Specific tumor markers in diagnostic cytology. Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates.

Authors:  A E Walts; J W Said
Journal:  Acta Cytol       Date:  1983 Jul-Aug       Impact factor: 2.319

8.  Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions.

Authors:  M Sehested; E Ralfkjaer; J Rasmussen
Journal:  Acta Cytol       Date:  1983 Mar-Apr       Impact factor: 2.319

9.  Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.

Authors:  A To; D V Coleman; D P Dearnaley; M G Ormerod; K Steele; A M Neville
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

10.  Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions.

Authors:  M Nap; K A ten Hoor; G J Fleuren
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.